P3.01-13 Prognosis of Non-Driver, Never Smoker Metastatic Non-Small Lung Cancer (NSCLC)

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1573
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Approval Summary: Pemetrexed Maintenance Therapy of Advanced/Metastatic Nonsquamous, Non-Small Cell Lung Cancer (NSCLC)

Oncologist
Cancer ResearchMedicineOncology
2010English

P3.01-109 Real-World Patient-Reported Outcome Assessment of Patients With Metastatic Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Nivolumab in Metastatic Non–Small Cell Lung Cancer

Journal of the Advanced Practitioner in Oncology
2016English

Third Generation EGFR TKI Landscape for Metastatic EGFR Mutant Non-Small Cell Lung Cancer (NSCLC)

Expert Review of Anticancer Therapy
OncologyPharmacology
2019English

P3.01-081 Overall Survival (OS) of Locally Advanced Non-Small Cell Lung Cancer (NSCLC) After Negative Invasive Mediastinal Staging

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

Checkpoint Inhibitors in Squamous Non-Small Cell Lung Cancer (NSCLC)

Open Access Journal of Oncology and Medicine
2018English

Smoking Cessation Before Initiation of Chemotherapy in Metastatic Non-Small Cell Lung Cancer: Influence on Prognosis

Jornal Brasileiro de Pneumologia
PulmonaryRespiratory Medicine
2018English

P3.01-71 Results of Extended Resection in T4 Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P3.01-30 Treatment Sequencing in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer (NSCLC) in Japan

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy